Related Experiment Video
Updated: May 21, 2026

The Adventures of Fundi Intervention Based on the Cognitive and Emotional Processing in Attention Deficit Hyperactive Disorder Patients
Published on: June 12, 2020
Agomelatine treatment with adolescents with ADHD
1Department of Child and Adolescent Psychiatry, Saechsisches Krankenhaus D-08228, Rodewisch, Germany. helmutniederhofer@yahoo.de
Objective:
Antidepressants, in particular Atomextine, along with stimulants have demonstrated benefit in the treatment of ADHD. Agomelatine is a new antidepressant with additional affinities to the melatonergic system. As ADHD has been associated with sleep disorders, it is assumed that Agomelatiine might serve as a therapeutic alternative to treat patients with the ADHD refractory to first line medications.
Method:
Ten late adolescents were evaluated in a placebo controlled manner.
Results:
Agomelatine's effect was superior to that of placebo but appeared to be less than that of first line medications such as methylphenidate.
Conclusion:
Agomelatine may be a useful second line medication for individuals with ADHD, particularly if they suffer from additional sleep disorders.
More Related Videos
10:02Event Related Potentials (ERPs) and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder (ADHD)
Published on: March 12, 2020
13:09Using Brain Activation (nir-HEG/Q-EEG) and Execution Measures (CPTs) in a ADHD Assessment Protocol
Published on: April 1, 2018
Related Concept Videos
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Antidepressant Drugs: MAOIs and Other Agents
Alzheimer's Disease: Treatment
Drug Therapy
Antianxiety Medications
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Antidepressant Drugs: Overview